gprc5d-targeted car t-cell therapy for rrmm: phase 1 study outcomes of bms-986393 (cc-95266)
Published 1 year ago • 599 plays • Length 6:58Download video MP4
Download video MP3
Similar videos
-
8:06
clinical activity of bms-986393, a car t cell therapy directed at gprc5d, in pts with rrmm
-
1:10
bms-986393: gprc5d-targeted car for r/r myeloma
-
2:27
bms-986393, a novel anti-gprc5d car-t cell therapy, in multiple myeloma
-
0:36
promise of gprc5d-targeted car-t therapies in multiple myeloma
-
6:28
phase i crb-402 study of the bcma-targeted car t cell therapy bb21217 in pts w/rr multiple myeloma
-
9:01
updated results of bcma/cd19 dual-targeting fast car-t gc012f dual-targeting car-t in rrmm
-
11:18
car-t cells: engineered cancer killers
-
13:19
using the immune system to fight multiple myeloma
-
6:31
what is t cell exhaustion?
-
3:47
what is car t-cell therapy?
-
7:49
idecabtagene vicleucel, a bcma-directed car t cell therapy, in rrmm: updated karmma results
-
5:18
car t-cell therapies | high impact topic (hit)
-
1:01
how are imids and celmods being explored in combo with car t-cell therapy?
-
1:57
car t-cell therapy in myeloma
-
1:15
how do car-t cells kill myeloma cells?
-
15:50
understanding car t therapy: a groundbreaking approach to myeloma treatment
-
0:49
car t-cell therapy for multiple myeloma
-
3:52
is car t-cell therapy being used to treat newly diagnosed multiple myeloma?
-
5:55
car t-cell therapy for multiple myeloma
-
6:23
late-breaking abstract: first-in-man trial of car t cells in myeloma
-
3:57
what should care providers of myeloma patients know about car t-cell therapy?
-
7:17
updates on car t-cell therapy for myeloma